The Effects of A Proprietary Spearmint Extract on Cognitive Performance

A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial to Assess the Effects of A Proprietary Spearmint Extract on Cognitive Performance, Mood, and Sleep in Men and Women

This study was designed to evaluate the chronic effects of a proprietary spearmint extract over 90 days of supplementation on aspects of cognitive performance (cognitive function and active reaction time), subjective mood, and sleep quality in healthy men and women.

Inclusion Criteria:

• Men and pre-menopausal women, 18-50 years of age.
• Body mass index 18.5-29.99 kg/m2, inclusive or body mass index 30.0-34.99 kg/m2 and body fat via bioimpedance <39% for women aged 18-39y, <40% for women aged 40-50y, <25% for men aged 18-39y, <28% for men aged 40-50y.
• Participant has at least a high school diploma or the equivalent.
• Participant is recreationally active.
• Participant is judged by the Investigator to be in general good health.
• Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.

Exclusion Criteria:

• Participant is unable to understand and/or perform required tests.
• Participant is unwilling to maintain normal dietary (including vitamins and supplements), exercise, sleep and medication patterns throughout the study.
• Participant is a habitual consumer of mint tea defined as >8oz per day.
• Participant is regularly taking a cognitive enhancing supplement.
• Participant has a history or presence of a clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
• Participant has a sleep disorder or occupation where sleep during the overnight hours is irregular.
• Participant is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period.
• Participant is a current user of tobacco (defined as tobacco use within the previous 6 months).